Coherent (COHR) Is Up 13.1% After AI-Driven Q4 2026 Guidance Tops Estimates – Has The Bull Case Changed?

• In recent days, Coherent has drawn attention after issuing fiscal Q4 2026 guidance above analyst expectations and preparing to report its June-quarter results, with the company highlighting strong AI-related semiconductor and data center optics demand supported by long-term customer commitments and a record backlog.
• What stands out is how this AI infrastructure momentum coincides with increasingly positive analyst sentiment and a Zacks Rank #2 rating, positioning the upcoming August 12 earnings release as an important test of whether Coherent’s recent operational strength and backlog translate into sustained earnings power.
• We’ll now examine how this upbeat AI-driven earnings outlook and above-consensus guidance could influence Coherent’s existing investment narrative.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Coherent Investment Narrative Recap

To own Coherent today, you need to believe its AI datacenter optics and long term customer commitments can offset cyclicality in industrial and materials end markets. The latest above consensus Q4 2026 guidance and strong AI commentary reinforce the near term earnings catalyst around the August 12 report, while also sharpening the key risk that any slowdown or pause in hyperscaler and data center spending could quickly expose Coherent’s premium valuation and volatile share price.

The upcoming August 12 earnings release is especially important in light of Coherent’s raised Q4 revenue outlook of US$1.91 billion to US$2.05 billion, which topped prior analyst expectations. This guidance sits alongside record AI driven backlog and stronger analyst sentiment, including a Zacks Rank #2, making the print a focal point for testing whether current AI optics strength is broad and resilient enough to support management’s capacity investments and justify the company’s richer sales multiple.

Yet against this optimism, investors should also be aware that concentrated hyperscaler demand could quickly become a liability if capex plans shift or orders are deferred...

Read the full narrative on Coherent (it's free!)

Coherent's narrative projects $15.7 billion revenue and $2.6 billion earnings by 2029.

Uncover how Coherent's forecasts yield a $384.45 fair value, a 23% upside to its current price.

Exploring Other Perspectives

Compared with the baseline view, the most bullish analysts were already assuming revenue could reach about US$15.9 billion and earnings US$2.9 billion, which is a much more optimistic take on Coherent’s AI optics opportunity and CHIPS fueled capacity bets, and the latest earnings guidance and AI commentary could either reinforce or challenge that story depending on how the data center cycle actually unfolds.

Explore 5 other fair value estimates on Coherent - why the stock might be worth as much as 48% more than the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Coherent research is our analysis highlighting 4 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Coherent research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Coherent's overall financial health at a glance.

Curious About Other Options?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• Rare earth metals are the new gold rush. Find out which 29 stocks are leading the charge.
• AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com